H

Hua Medicine
HKEX:2552

Watchlist Manager
Hua Medicine
HKEX:2552
Watchlist
Price: 1.53 HKD 4.79% Market Closed
Market Cap: 1.5B HKD
Have any thoughts about
Hua Medicine?
Write Note

Intrinsic Value

The intrinsic value of one Hua Medicine stock under the Base Case scenario is 0.34 HKD. Compared to the current market price of 1.53 HKD, Hua Medicine is Overvalued by 78%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
0.34 HKD
Overvaluation 78%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Hua Medicine

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Hua Medicine cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Hua Medicine?
Bearish
Neutral
Bullish

Fundamental Analysis

1.53 HKD
+4.79%
+4.79%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Hua Medicine
CN
Pharmaceuticals
Market Cap
1.5B HKD
IPO
Sep 14, 2018
Employees
146
China
Market Cap
1.5B HKD
Industry
Pharmaceuticals
IPO
Sep 14, 2018
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Hua Medicine

Provide an overview of the primary business activities
of Hua Medicine.

What unique competitive advantages
does Hua Medicine hold over its rivals?

What risks and challenges
does Hua Medicine face in the near future?

Summarize the latest earnings call
of Hua Medicine.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hua Medicine.

Provide P/S
for Hua Medicine.

Provide P/E
for Hua Medicine.

Provide P/OCF
for Hua Medicine.

Provide P/FCFE
for Hua Medicine.

Provide P/B
for Hua Medicine.

Provide EV/S
for Hua Medicine.

Provide EV/GP
for Hua Medicine.

Provide EV/EBITDA
for Hua Medicine.

Provide EV/EBIT
for Hua Medicine.

Provide EV/OCF
for Hua Medicine.

Provide EV/FCFF
for Hua Medicine.

Provide EV/IC
for Hua Medicine.

Show me price targets
for Hua Medicine made by professional analysts.

What are the Revenue projections
for Hua Medicine?

How accurate were the past Revenue estimates
for Hua Medicine?

What are the Net Income projections
for Hua Medicine?

How accurate were the past Net Income estimates
for Hua Medicine?

What are the EPS projections
for Hua Medicine?

How accurate were the past EPS estimates
for Hua Medicine?

What are the EBIT projections
for Hua Medicine?

How accurate were the past EBIT estimates
for Hua Medicine?

Compare the revenue forecasts
for Hua Medicine with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hua Medicine and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hua Medicine against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hua Medicine compared to its peers.

Compare the P/E ratios
of Hua Medicine against its peers.

Discuss the investment returns and shareholder value creation
comparing Hua Medicine with its peers.

Analyze the financial leverage
of Hua Medicine compared to its main competitors.

Show all profitability ratios
for Hua Medicine.

Provide ROE
for Hua Medicine.

Provide ROA
for Hua Medicine.

Provide ROIC
for Hua Medicine.

Provide ROCE
for Hua Medicine.

Provide Gross Margin
for Hua Medicine.

Provide Operating Margin
for Hua Medicine.

Provide Net Margin
for Hua Medicine.

Provide FCF Margin
for Hua Medicine.

Show all solvency ratios
for Hua Medicine.

Provide D/E Ratio
for Hua Medicine.

Provide D/A Ratio
for Hua Medicine.

Provide Interest Coverage Ratio
for Hua Medicine.

Provide Altman Z-Score Ratio
for Hua Medicine.

Provide Quick Ratio
for Hua Medicine.

Provide Current Ratio
for Hua Medicine.

Provide Cash Ratio
for Hua Medicine.

What is the historical Revenue growth
over the last 5 years for Hua Medicine?

What is the historical Net Income growth
over the last 5 years for Hua Medicine?

What is the current Free Cash Flow
of Hua Medicine?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hua Medicine.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hua Medicine

Current Assets 1.5B
Cash & Short-Term Investments 1.3B
Receivables 62.9m
Other Current Assets 114.4m
Non-Current Assets 138.6m
PP&E 101.3m
Intangibles 27.5m
Other Non-Current Assets 9.7m
Current Liabilities 311.1m
Accounts Payable 210.2m
Accrued Liabilities 19.4m
Other Current Liabilities 81.4m
Non-Current Liabilities 1.4B
Long-Term Debt 180.2m
Other Non-Current Liabilities 1.2B
Efficiency

Earnings Waterfall
Hua Medicine

Revenue
108.9m CNY
Cost of Revenue
-67.9m CNY
Gross Profit
41.1m CNY
Operating Expenses
-310.2m CNY
Operating Income
-269.1m CNY
Other Expenses
5.8m CNY
Net Income
-263.4m CNY

Free Cash Flow Analysis
Hua Medicine

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hua Medicine's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
ROIC is Increasing
Positive Gross Profit
Exceptional 1-Year Revenue Growth
31/100
Profitability
Score

Hua Medicine's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hua Medicine's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
60/100
Solvency
Score

Hua Medicine's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hua Medicine

There are no price targets for Hua Medicine.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Hua Medicine?

Click here to dive deeper.

Dividends

Hua Medicine
does not pay dividends
Shareholder Yield

Current shareholder yield for Hua Medicine is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Hua Medicine stock?

The intrinsic value of one Hua Medicine stock under the Base Case scenario is 0.34 HKD.

Is Hua Medicine stock undervalued or overvalued?

Compared to the current market price of 1.53 HKD, Hua Medicine is Overvalued by 78%.

Back to Top